|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li D, Wu C, Zheng Y, Zhong W and Wu F:
Incidence and mortality of colorectal cancer in Shanghai from 2003
to 2007. Zhongguo Zhongliu. 20:413–418. 2011.
|
|
3
|
Woolf CM: A genetic study of carcinoma of
the large intestine. Am J Hum Genet. 10:42–47. 1958.PubMed/NCBI
|
|
4
|
Winawer SJ, Zauber AG, Gerdes H, O'Brien
MJ, Gottlieb LS, Sternberg SS, Bond JH, Waye JD, Schapiro M and
Panish JF: Risk of colorectal cancer in the families of patients
with adenomatous polyps National Polyp Study Workgroup. N Engl J
Med. 334:82–87. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Magrone T and Jirillo E: The interaction
between gut microbiota and age-related changes in immune function
and inflammation. Immun Ageing. 10:312013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O'Toole PW: Changes in the intestinal
microbiota from adulthood through to old age. Clin Microbiol
Infect. 18:44–46. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
DiBaise JK, Frank DN and Mathur R: Impact
of the gut microbiota on the development of obesity: Current
concepts. Am J Gastroenterol. 1(Suppl): 22–27. 2012. View Article : Google Scholar
|
|
8
|
Kallus SJ and Brandt LJ: The intestinal
microbiota and obesity. J Clin Gastroenterol. 46:16–24. 2012.
View Article : Google Scholar
|
|
9
|
Rubinstein MR, Wang X, Liu W, Hao Y, Cai
GF and Han YW: Fusobacterium nucleatum promotes colorectal
carcinogenesis by modulating e-cadherin/β-catenin signaling via its
FadA adhesin. Cell Host Microbe. 14:195–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sobhani I, Amiot A, Le Baleur Y, Levy M,
Auriault M, Van Nhieu JT and Delchier JC: Microbial dysbiosis and
colon carcinogenesis: could colon cancer be considered a
bacteria-related disease? Therap Adv Gastroenterol. 6:215–229.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tjalsma H, Boleij A, Marchesi JR and
Dutilh BE: A bacterial driver-passenger model for colorectal
cancer: Beyond the usual suspects. Nat Rev Microbiol. 10:575–582.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ley RE, Peterson DA and Gordon JI:
Ecological and evolutionary forces shaping microbial diversity in
the human intestine. Cell. 124:837–848. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Purchiaroni F, Tortora A, Gabrielli M,
Bertucci F, Gigante G, Ianiro G, Ojetti V, Scarpellini E and
Gasbarrini A: The role of intestinal microbiota and the immune
system. Eur Rev Med Pharmacol Sci. 17:323–333. 2013.PubMed/NCBI
|
|
14
|
Xu X, Xu P, Ma C, Tang J and Zhang X: Gut
microbiota, host health and polysaccharides. Biotechnol Adv.
31:318–337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Compare D and Nardone G: The
bacteria-hypothesis of colorectal cancer: Pathogenetic and
therapeutic implications. Transl Gastrointest Cancer. 3:44–53.
2014.
|
|
16
|
Rowland I: Probiotics and colorectal
cancer risk. Br J Nutr. 91:805–807. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Uccello M, Malaguarnera G, Basile F,
D'agata V, Malaguarnera M, Bertino G, Vacante M, Drago F and Biondi
A: Potential role of probiotics on colorectal cancer prevention.
BMC Surg. 12:S352012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Delia P, Sansotta G, Donato V, Frosina P,
Messina G, De Renzis C and Famularo G: Use of probiotics for
prevention of radiation-induced diarrhea. World J Gastroenterol.
13:912–915. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Famularo G, Mosca L, Minisola G,
Trinchieri V and De Simone C: Probiotic lactobacilli: A new
perspective for the treatment of inflammatory bowel disease. Curr
Pharm Des. 9:1973–1980. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ljungh A and Wadström T: Lactic acid
bacteria as probiotics. Curr Issues Intest Microbiol. 7:73–89.
2006.PubMed/NCBI
|
|
21
|
Allen SJ, Wareham K, Wang D, Bradley C,
Hutchings H, Harris W, Dhar A, Brown H, Foden A, Gravenor MB, et
al: Lactobacilli and bifidobacteria in the prevention of
antibiotic-associated diarrhoea and Clostridium difficile diarrhoea
in older inpatients (PLACIDE): A randomised, double-blind,
placebo-controlled, multicentre trial. Lancet. 382:1249–1257. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mackowiak PA: Recycling metchnikoff:
Probiotics, the intestinal microbiome and the quest for long life.
Front Public Health. 1:522013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Allen SJ, Martinez EG, Gregorio GV and
Dans LF: Probiotics for treating acute infectious diarrhoea.
Cochrane Database Syst Rev. 10:CD0030482010.
|
|
24
|
Chen CC, Kong MS, Lai MW, Chao HC, Chang
KW, Chen SY, Huang YC, Chiu CH, Li WC, Lin PY, et al: Probiotics
have clinical, microbiologic and immunologic efficacy in acute
infectious diarrhea. Pediatr Infect Dis J. 29:135–138. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hempel S, Newberry SJ, Maher AR, Wang Z,
Miles JN, Shanman R, Johnsen B and Shekelle PG: Probiotics for the
prevention and treatment of antibiotic-associated diarrhea a
systematic review and meta-analysis. JAMA. 307:1959–1969. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Koebnick C, Wagner I, Leitzmann P, Stern U
and Zunft HJ: Probiotic beverage containing Lactobacillus casei
Shirota improves gastrointestinal symptoms in patients with chronic
constipation. Can J Gastroenterol. 17:655–659. 2003.PubMed/NCBI
|
|
27
|
Ouwehand AC, Lagström H, Suomalainen T and
Salminen S: Effect of probiotics on constipation, fecal
azoreductase activity and fecal mucin content in the elderly. Ann
Nutr Metab. 46:159–162. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
de Milliano I, Tabbers MM, van der Post JA
and Benninga MA: Is a multispecies probiotic mixture effective in
constipation during pregnancy? 'A pilot study'. Nutr J. 11:802012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Persborn M and Söderholm JD: Commentary:
the effects of probiotics on barrier function and mucosal pouch
microbiota during maintenance treatment for severe pouchitis in
patients with ulcerative colitis-authors' reply. Aliment Pharmacol
Ther. 38:1406–1407. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tursi A, Brandimarte G, Papa A, Giglio A,
Elisei W, Giorgetti GM, Forti G, Morini S, Hassan C, Pistoia MA, et
al: Treatment of relapsing mild-to-moderate ulcerative colitis with
the probiotic Vs.L#3 as adjunctive to a standard pharmaceutical
treatment: A double-blind, randomized, placebo-controlled study. Am
J Gastroenterol. 105:2218–2227. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Müllner K, Miheller P, Herszényi L and
Tulassay Z: Probiotics in the management of Crohn's disease and
ulcerative colitis. Curr Pharm Des. 20:4556–4560. 2014. View Article : Google Scholar
|
|
32
|
Huebner C, Ding Y, Petermann I, Knapp C
and Ferguson LR: The probiotic Escherichia coli Nissle 1917 reduces
pathogen invasion and modulates cytokine expression in Caco-2 cells
infected with Crohn's disease-associated E. coli LF82. Appl Environ
Microbiol. 77:2541–2544. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kõljalg U, Nilsson RH, Abarenkov K,
Tedersoo L, Taylor AF, Bahram M, Bates ST, Bruns TD,
Bengtsson-Palme J, Callaghan TM, et al: Towards a unified paradigm
for sequence-based identification of fungi. Mol Ecol. 22:5271–5277.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hamady M, Walker JJ, Harris JK, Gold NJ
and Knight R: Error-correcting barcoded primers for pyrosequencing
hundreds of samples in multiplex. Nat Methods. 5:235–237. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Edgar RC: UPARSE: Highly accurate OTU
sequences from microbial amplicon reads. Nat Methods. 10:996–998.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Quast C, Pruesse E, Yilmaz P, Gerken J,
Schweer T, Yarza P, Peplies J and Glöckner FO: The SILVA ribosomal
RNA gene database project: Improved data processing and web-based
tools. Nucleic Acids Res. 41:D590–D596. 2013. View Article : Google Scholar :
|
|
37
|
DeSantis TZ, Hugenholtz P, Larsen N, Rojas
M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P and Andersen GL:
Greengenes, a chimera-checked 16S rRNA gene database and workbench
compatible with ARB. Appl Environ Microbiol. 72:5069–5072. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Appleyard CB, Cruz ML, Isidro AA, Arthur
JC, Jobin C and De Simone C: Pretreatment with the probiotic VSL#3
delays transition from inflammation to dysplasia in a rat model of
colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol.
301:G1004–G1013. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fotiadis CI, Stoidis CN, Spyropoulos BG
and Zografos ED: Role of probiotics, prebiotics and synbiotics in
chemoprevention for colorectal cancer. World J Gastroenterol.
14:6453–6457. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wollowski I, Rechkemmer G and Pool-Zobel
BL: Protective role of probiotics and prebiotics in colon cancer.
Am J Clin Nutr. 73:451S–455S. 2001.PubMed/NCBI
|
|
41
|
Bertkova I, Hijova E, Chmelarova A,
Mojzisova G, Petrasova D, Strojny L, Bomba A and Zitnan R: The
effect of probiotic microorganisms and bioactive compounds on
chemically induced carcinogenesis in rats. Neoplasma. 57:422–428.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vipperla K and O'Keefe SJ: The microbiota
and its metabolites in colonic mucosal health and cancer risk. Nutr
Clin Pract. 27:624–635. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang J, Tang H, Zhang C, Zhao Y, Derrien
M, Rocher E, van-Hylckama Vlieg JE, Strissel K, Zhao L, Obin M and
Shen J: Modulation of gut microbiota during probiotic-mediated
attenuation of metabolic syndrome in high fat diet-fed mice. ISME.
9:1–15. 2015. View Article : Google Scholar
|
|
44
|
Kostic AD, Gevers D, Pedamallu CS, Michaud
M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, et
al: Genomic analysis identifies association of Fusobacterium with
colorectal carcinoma. Genome Res. 22:292–298. 2012. View Article : Google Scholar :
|
|
45
|
Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang
X, Jia W, Cai S and Zhao L: Structural segregation of gut
microbiota between colorectal cancer patients and healthy
volunteers. ISME J. 6:320–329. 2012. View Article : Google Scholar :
|
|
46
|
Allen-Vercoe E, Strauss J and Chadee K:
Fusobacterium nucleatum: An emerging gut pathogen? Gut Microbes.
2:294–298. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Strauss J, Kaplan GG, Beck PL, Rioux K,
Panaccione R, Devinney R, Lynch T and Allen-Vercoe E: Invasive
potential of gut mucosa-derived Fusobacterium nucleatum positively
correlates with IBD status of the host. Inflamm Bowel Dis.
17:1971–1978. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Arthur JC and Jobin C: The struggle
within: Microbial influences on colorectal cancer. Inflamm Bowel
Dis. 17:396–409. 2011. View Article : Google Scholar
|
|
49
|
Chaikham P and Apichartsrangkoon A:
Effects of encapsulated Lactobacillus acidophilus along with
pasteurized longan juice on the colon microbiota residing in a
dynamic simulator of the human intestinal microbial ecosystem. Appl
Microbiol Biotechnol. 98:485–495. 2014. View Article : Google Scholar
|
